Document Detail


Risk Factors for Peritoneal Recurrence in Stage II/III Gastric Cancer Patients Who Received S-1 Adjuvant Chemotherapy After D2 Gastrectomy.
MedLine Citation:
PMID:  22143578     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: The peritoneum is still the most frequent site of recurrence in stage II/III gastric cancer patients, although the survival rate was improved by the introduction of S-1 adjuvant chemotherapy. The objective of this retrospective study was to clarify the risk factors for peritoneal recurrence in patients who received S-1 adjuvant chemotherapy. METHODS: Peritoneal recurrence-free survival was examined in 100 gastric cancer patients who underwent curative D2 surgery, which were diagnosed with stage II or III disease pathologically, and received adjuvant S-1 between June 2002 and March 2011. The univariate and multivariate analyses were performed to identify risk factors by a Cox proportional hazards analysis. RESULTS: The P-RFS was 64.3% at 3 years and 58.8% at 5 years. A total of 18 patients were diagnosed with peritoneal recurrence. The macroscopic tumor diameter, depth of tumor invasion, and lymph node metastasis were the significant factors identified by the univariate analysis, while the tumor diameter and lymph node metastasis were the only significant independent risk factors identified by the multivariate analysis. CONCLUSIONS: The macroscopic tumor diameter and presence of lymph node metastasis were the most important risk factors for peritoneal recurrence. When patients had these risk factors, S-1 was not sufficient to inhibit peritoneal recurrence. A novel adjuvant chemotherapeutic agent targeting peritoneal metastasis in these patients should be developed.
Authors:
Toru Aoyama; Takaki Yoshikawa; Tsutomu Hayashi; Hiroshi Kuwabara; Yo Mikayama; Takashi Ogata; Haruhiko Cho; Akira Tsuburaya
Related Documents :
19718358 - Prognostic determinants for survival after resection/ablation of a large hepatocellular...
15827438 - The surveillance and diagnosis of hepatocellular carcinoma.
19303988 - Major hepatic resection for hepatocellular carcinoma with or without portal vein emboli...
20066748 - Transarterial chemoembolization as initial treatment for unresectable hepatocellular ca...
23049298 - Monitoring of bcr-abl levels in chronic myeloid leukemia patients treated with imatinib...
18692248 - Management of periocular cutaneous melanoma with a staged excision technique and perman...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-6
Journal Detail:
Title:  Annals of surgical oncology     Volume:  -     ISSN:  1534-4681     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9420840     Medline TA:  Ann Surg Oncol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Surveillance of pancreatic cancer patients after surgical resection.
Next Document:  Activation of the G-protein-coupled receptor GPR30 induces anxiogenic effects in mice, similar to oe...